MilliporeSigma , the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, was named the winner of a <a ...

For its commitment to renewable energy and advancing the green power market nationwide, MilliporeSigma has won a 2024 Green ...

PictorLabs has completed a $30m Series B funding round to accelerate its AI-powered virtual staining technology. This ...

The gross proceeds to the Company from the exercise of the Existing Warrants together with the sale of the new warrants is expected to be approximately $6.2 million. The closing of the transaction is ...

PictorLabs, a pioneering software company transforming histopathology with AI-powered virtual staining, announced today the successful completion of its $30 million Series B funding round. The round ...

However, there is a lack of knowledge about how externally applied currents affect neuronal spiking activity in cerebellar circuits in vivo. We investigated how Cb-tDCS affects the firing rate of ...

Development methodologies combine old and new techniques, but getting any new material into high-volume manufacturing is a ...

Head of Development Unit Neurology & Immunology for the Healthcare business of Merck KGaA, Darmstadt, Germany. “This treatment approach holds the promise of achieving a high degree of disease ...

Merck is building a new biotech development facility in Corsier-sur-Vevey, Switzerland. Credit: Merck KGaA, Darmstadt, Germany. The company celebrated the ground-breaking ceremony of the new biotech ...

Merck in Germany was possibly the earliest company to move in this direction. Originating as a pharmacy founded in Darmstadt in 1668, it was in 1827 that Heinrich Emanuel Merck began the ...

Global Regulatory and Scientific Policy, The Healthcare Business of Merck KGaA, Darmstadt, Germany. *Corresponding Author: Marén U. Koban, Global Regulatory Affairs, The Healthcare Business of Merck ...